Stocks Consumer discretionary YCBD
NYSE · Consumer discretionarycbdMD, Inc. (YCBD)
cbdMD, Inc. brought in $20.9M of revenue over the twelve months to June 30, 2026. It posted a net loss of $2.9M. In fiscal 2025 capital spending exceeded operating cash flow by $1.6M. At June 30, 2026 it held $2.1M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.
Key facts about cbdMD, Inc.
- Net worth
- cbdMD, Inc. has a market value (market cap) of $4.3M at the latest share price, and shareholders' equity of $8.2M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $19.2M (-3.7% year on year), with a net loss of $2M. Over the 12 months to June 30, 2026: revenue $20.9M, net loss $2.9M.
- Cash flow
- In fiscal 2025 operations used $1.5M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 13, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- cbdMD, Inc.'s next report is expected around December 18, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
What cbdMD, Inc. does
cbdMD, Inc. is registered with the SEC under industry code SIC 2844 (Perfumes, Cosmetics & Other Toilet Preparations). Its shares trade on NYSE under the ticker YCBD.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $19.2M | -$2M | -$1.09 | -$1.6M |
| 2024 | $19.9M | -$3.7M | -$14.29 | -$542.8K |
| 2023 | $25.1M | -$22.9M | -$106.34 | -$4.6M |
| 2022 | $37.1M | -$70.1M | -$445.46 | -$15.7M |
| 2021 | $47.3M | -$23.4M | -$168.85 | -$14.4M |
| 2020 | $41.9M | $12.6M | $100.59 | -$12M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where YCBD ranks in Consumer discretionary
Dividends
It paid out $2.6M in cash dividends.
| Fiscal year | Per share | Paid out | Of profit |
|---|---|---|---|
| 2021 | n/a | $2.6M | n/a |
| 2020 | n/a | $366.9K | 3% |
| 2019 | n/a | $0 | n/a |
Latest SEC filings
What cbdMD, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 2, 2026
- August 13, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 21% to $5.6M versus the same quarter last year; diluted EPS -$0.11 versus -$0.21.
- May 20, 2026
- May 14, 2026Quarterly report 10-Q · period to March 31, 2026Revenue rose 19% to $5.6M versus the same quarter last year; diluted EPS -$0.08 versus -$1.90.
- April 15, 2026Other event 8-K
- April 1, 2026
- February 20, 2026
- February 17, 2026Quarterly report 10-Q · period to December 31, 2025Revenue fell 1.9% to $5M versus the same quarter last year; diluted EPS -$0.04 versus -$1.73.
- February 12, 2026Proxy statement DEF 14A
- February 2, 2026Preliminary proxy statement PRE 14A
Insider trades
What the people running cbdMD, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| April 14, 2026 | Raines William F IIIDirector | Received as pay | 1,572 | - |
| April 14, 2026 | Stephen Scott G.Director | Received as pay | 1,572 | - |
| April 14, 2026 | Sellers Bakari T.Director | Received as pay | 1,572 | - |
| April 14, 2026 | Swift Sibyl NicholeDirector | Received as pay | 1,572 | - |
| April 14, 2026 | Roe Kevin CharlesDirector | Received as pay | 1,572 | - |
| April 14, 2026 | Porter Jeffrey HDirector | Received as pay | 1,572 | - |
| December 17, 2025 | Crosnoe Clark R.10% owner | Soldindirect | 461,725 | $1.1M |
| December 17, 2025 | Crosnoe Clark R.10% owner | Soldindirect | 69,875 | $163.8K |
Who owns YCBD
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Porter Jeffrey H13D, may seek influence | 6.4% | May 8, 2025 |
Largest institutional holders
Insiders
8 insiders reported holding 588,005 shares in total, about $232.3K at the last price.
| Holder | Shares |
|---|---|
| Kennedy Thomas RonanCEO and CFO, Director | 513,722 |
| Roe Kevin CharlesDirector | 26,707 |
| Crosnoe Clark R.10% owner | 17,87517,875 held indirectly |
| Raines William F IIIDirector | 13,676 |
| Stephen Scott G.Director | 4,412 |
| Sellers Bakari T.Director | 4,324 |
| Swift Sibyl NicholeDirector | 4,145 |
| Porter Jeffrey HDirector | 3,144 |
Questions about YCBD
What does cbdMD, Inc. do?
cbdMD, Inc. is a company in the Consumer discretionary sector, listed on NYSE as YCBD. Its shares trade on NYSE under the ticker YCBD.
What is cbdMD, Inc.'s net worth?
cbdMD, Inc. has a market value (market cap) of $4.3M at the latest share price, and shareholders' equity of $8.2M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is cbdMD, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $2.9M on revenue of $20.9M.
How much revenue does cbdMD, Inc. make?
Over the twelve months to June 30, 2026 cbdMD, Inc. reported revenue of $20.9M.
When did cbdMD, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the material agreement from September 2, 2026.
When is cbdMD, Inc.'s next earnings report?
cbdMD, Inc.'s next report is expected around December 18, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare YCBD with
Follow YCBD
Get an email when cbdMD, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values cbdMD, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.